Thomas Jefferson University Hospital
 
JEFFERSON PANCREATIC, BILIARY, AND RELATED CANCERS CENTER

Jefferson Pancreas Tumor Registry (JPTR)

About the Registry
Why should I register?

How do I join?

Study Investigators

Forms & Questionnaires

Contact Us

Why Should I Register?     

You and your family may or may not benefit directly from your participation in this study.  However, although you may not benefit directly from this research, there may be a benefit to society, in general, from a better understanding of the risk factors for pancreatic cancer and increased knowledge of the occurrence of pancreas tumors in families.  Any information obtained from this research study which may be important to your health or disease progression, will be shared with you.  Additional benefits from your participation in this study may include:

  1. Identification of risk factors for pancreas cancer,
  2. Discovery of biomarkers that can be used in early detection of pancreas cancer and for screening high risk groups,
  3. Identification of genes that may aid in individualizing treatment of pancreas cancer,  as well as identifying new treatment strategies.

The JPTR is a longitudinal study in which participants may engage in long-term follow-up and receive information regarding scientific and epidemiological breakthroughs in pancreas cancer.